MediLexicon News - New Human Immunology Research Awards To Help Fight Emerging Infectious Diseases Announced By NIAID

news headlines

email to a friend

printer friendly

New Human Immunology Research Awards To Help Fight Emerging Infectious Diseases Announced By NIAID

Main Category: Immune System / Vaccines
Also Included In: Allergy | Bio-terrorism / Terrorism | Infectious Diseases / Bacteria / Viruses
Article Date: 06 Nov 2009

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

The grants were awarded to the Cooperative Centers for Translational Research on Human Immunology and Biodefense (CCHI) and the Immune Mechanisms of Virus Control (IMVC), NIAID also has received approximately $21 million under the American Recovery and Reinvestment Act to supplement these two programs and fund some additional researchers. This funding is part of the $5 billion awarded by NIH in FY 2009 for research projects under the Recovery Act.

The long-term goal of the CCHI and IMVC programs is to identify new vaccines and drug targets.

"A better understanding of how the human immune system responds to these infections should provide new approaches for developing prevention tools and therapeutics," says Anthony S. Fauci, M.D., director of NIAID, the lead Institute at NIH responsible for immunology and biodefense research.

The CCHI program, established in 2003, focuses on basic research and preclinical research of potential benefit to humans. CCHI research will include developing new vaccines to protect against infectious diseases such as influenza, dengue fever, anthrax and hepatitis C; understanding how immune protection is achieved; and determining how harmless microorganisms in the lungs, intestines and other mucosal surfaces protect against harmful microbes that enter the body through these sites.

The following eight investigators have been awarded a total of approximately $130 million over the next five years under the CCHI program:

Rafi Ahmed, Ph.D., Emory University, Atlanta
Jacques Banchereau, Ph.D., Baylor Research Institute, Dallas
Raymond Chung, M.D., Massachusetts General Hospital, Boston
Kenneth Coggeshall, Ph.D., Okalahoma Medical Research Foundation, Oklahoma City
Mark Davis, Ph.D., Stanford University, Palo Alto, Calif.
Anne de Groot, M.D., University of Rhode Island, Providence
Alan Rothman, M.D., University of Massachusetts Medical Center, Worcester
Marcelo Sztein, M.D., University of Maryland School of Medicine, Baltimore

The following investigator has received two-year funding through the Recovery Act to participate in the CCHI program:

Donald Burke, M.D., University of Pittsburgh

The following investigators have received one year of supplemental Recovery Act funding in addition to their CCHI program funding:

Rafi Ahmed, Ph.D., Emory University, Atlanta
Jacques Banchereau, Ph.D., Baylor Research Institute, Dallas
Mark Davis, Ph.D., Stanford University, Palo Alto, Calif.

The IMVC program builds on a set of exploratory grants awarded in 2007. The current phase is a substantially larger effort that addresses key questions related to how the immune system responds to viruses.

IMVC investigators will use animal models and conduct studies in people to understand all aspects of the immune response to viruses, including early immune responses (innate, or inborn, immunity) and antibody and immune cell memory responses that protect against repeat infections (adaptive immunity). Since cells of mucosal tissue comprise the primary barrier to many viruses, mucosal immunity in the gut or lungs also will be studied.

Some specific IMVC projects include studying how the immune response in the brain combats rabies virus infection; identifying immune markers that correlate with surviving Ebola infection; and finding new drugs to treat viral infections.

The following 14 investigators have been awarded a total of approximately $78 million over the next five years under the IMVC program:

Glen Barber, Ph.D., University of Miami School of Medicine
Thomas Braciale, M.D., Ph.D., University Of Virginia, Charlottesville
David Brooks, Ph.D., University of California Los Angeles
Michael Gale, Ph.D., University of Washington School of Medicine, Seattle
Douglas Hooper, Ph.D., Thomas Jefferson University, Philadelphia
Curt Horvath, Ph.D., Northwestern University, Evanston, Ill.
Jae Jung, Ph.D., University of Southern California, Los Angeles
Robert Mason, M.D., National Jewish Medical and Research Center, Denver
Andrew Mellor, Ph.D., Medical College of Georgia, Augusta
Elke Muehlberger, Ph.D., Boston University School of Medicine
Luis Sigal, Ph.D., Fox Chase Cancer Center, Philadelphia
E. John Wherry, Ph.D., The Wistar Institute, Philadelphia
Yiping Yang, M.D., Ph.D., Duke University Medical Center, Durham, N.C.
Allan Zajac, Ph.D., University of Alabama at Birmingham, Birmingham

The following four awardees have received Recovery Act funding and will participate in the IMVC program for two years:

Joan Durbin, M.D., Children's Research Institute, Columbus, Ohio
Emilio Flano, Ph.D., Children's Research Institute, Columbus, Ohio
Gregg Milligan, Ph.D., University of Texas Med. Branch, Galveston
Thomas Moran, Ph.D., Mount Sinai School of Medicine, New York

"Developing vaccines and treatments for emerging pathogens continues to be a priority for NIAID," says Daniel Rotrosen, M.D., director of the NIAID Division of Allergy, Immunology and Transplantation. "The CCHI and IMVC programs will foster collaboration among many talented investigators working toward the common goal of understanding the human immune response to infectious diseases and developing more effective measures to prevent and treat infection."

Source: Julie Wu
NIH/National Institute of Allergy and Infectious Diseases

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.

< back to medical news

For any corrections of factual information, or to contact the editors please use our feedback form.

Send your press releases to

New Human Immunology Research Awards To Help Fight Emerging Infectious Diseases Announced By NIAID

PDA Medical Dictionary